CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-01 | Fishman Peter L. SVP, CFO | Option exercise | +313 | 7,774 | ||
| 2026-08-01 | Fishman Peter L. SVP, CFO | Shares withheld for taxes | −155 | $14.26 | $2K | 7,619 |
| 2026-08-01 | Fishman Peter L. SVP, CFO | Grant or award · Restricted Stock Unit | +313 | 0 | ||
| 2026-07-01 | Fishman Peter L. SVP, CFO | Option exercise | +2,447 | 8,667 | ||
| 2026-07-01 | Fishman Peter L. SVP, CFO | Shares withheld for taxes | −1,206 | $15.94 | $19K | 7,461 |
| 2026-07-01 | Fishman Peter L. SVP, CFO | Grant or award · Restricted Stock Unit | +2,447 | 0 | ||
| 2026-07-01 | Keenan David Paul EVP, Chief Operating Officer | Option exercise | +3,688 | 15,396 | ||
| 2026-07-01 | Keenan David Paul EVP, Chief Operating Officer | Shares withheld for taxes | −1,926 | $15.94 | $31K | 13,470 |
| 2026-07-01 | Keenan David Paul EVP, Chief Operating Officer | Grant or award · Restricted Stock Unit | +3,688 | 0 | ||
| 2026-07-01 | Ketchum Steven B EVP, Chief Scientific Officer | Option exercise | +3,688 | 44,567 | ||
| 2026-07-01 | Ketchum Steven B EVP, Chief Scientific Officer | Shares withheld for taxes | −1,887 | $15.94 | $30K | 42,680 |
| 2026-07-01 | Ketchum Steven B EVP, Chief Scientific Officer | Grant or award · Restricted Stock Unit | +3,688 | 0 | ||
| 2026-07-01 | Provoost Jonathan EVP, Chief Legal Officer | Option exercise | +3,688 | 5,888 | ||
| 2026-07-01 | Provoost Jonathan EVP, Chief Legal Officer | Shares withheld for taxes | −1,264 | $15.94 | $20K | 4,624 |
| 2026-07-01 | Provoost Jonathan EVP, Chief Legal Officer | Grant or award · Restricted Stock Unit | +3,688 | 0 | ||
| 2026-06-26 | Berg Aaron President and CEO | Option exercise | +6,250 | 88,845 | ||
| 2026-06-26 | Berg Aaron President and CEO | Shares withheld for taxes | −3,197 | $16.35 | $52K | 85,648 |
| 2026-06-26 | Berg Aaron President and CEO | Option exercise · Restricted Stock Unit | +6,250 | 6,250 | ||
| 2026-04-18 | Bonfiglio Patrice Eadon Director | Option exercise | +838 | 1,239 | ||
| 2026-04-18 | Bonfiglio Patrice Eadon Director | Shares withheld for taxes | −403 | $14.98 | $6K | 836 |
Page 1 of 44 · 875 trades